The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Arab-Brazilian Chamber holds Gulf talks
- Mauritania opens to Brazilian cattle embryos
- Invest Minas, Arab-Brazilian Chamber discuss ties
- Brazil 5th-largest foreign investment recipient
- Brazil and Saudi Arabia discuss energy
- IMF recommends economic diversification in Algeria
- Event connects small businesses to global markets
- Brazil’s chicken meat exports rise in June
